Aldara and selected skin cancers

Imiquimod is not a general treatment for every suspicious mark or every type of skin cancer. The cancer subtype, depth, position, borders, previous treatment, and ability to attend follow-up all influence whether a cream is reasonable or a procedure is preferred.

A dermatologist may take a skin sample before prescribing Aldara because lesions that look similar can behave differently. When used for a suitable superficial cancer, imiquimod stimulates a local immune response against abnormal cells. It cannot show the clinician a complete surgical margin, so careful selection and later examination matter. Deeper, aggressive, recurrent, or poorly defined cancers may require another form of treatment.

Mark or photograph the treatment boundary if your dermatologist recommends it, because inflammation can make the original lesion harder to see. Apply a thin layer only to the instructed skin, follow the prescribed application and wash-off schedule, and wash your hands afterward. Protect the area from avoidable sun exposure and do not cover it with an airtight dressing unless told to. Keep every planned review even if the visible mark disappears.

Contact the treating team if pain or inflammation becomes difficult to manage, the skin develops pus or spreading warmth, or you feel significantly unwell. A lesion that grows, becomes firm, repeatedly bleeds, ulcerates, or remains after the treatment reaction settles needs reassessment rather than another self-directed course. Seek urgent help for breathing difficulty, facial swelling, collapse, or widespread blistering.

Ask for the exact diagnosis and whether it was confirmed with a sample. Clarify why cream is suitable for this site, what alternative treatments could offer, how healing will be assessed, and what future change at the same spot should trigger an earlier appointment.